Macular Health Company Profile

12:44 EST 21st November 2017 | BioPortfolio

News Articles [405 Associated News Articles listed on BioPortfolio]

New Macular Society support group in Pontyclun – Glamorgan Gem

Glamorgan GemNew Macular Society support group in PontyclunGlamorgan GemA new support group is being launched to help increase the confidence and independence of people affected by macular degeneratio...

Can Assessment of Age-related Macular Degeneration Be Automated?

Automated assessment of age-related macular degeneration (AMD) from fundus images could play a role in managing the disease, according to a new study. Reuters Health Information

Pesticide Use and Age-Related Macular Degeneration in the Agricultural Health Study

Introduction Age-related macular degeneration (AMD) is a degenerative condition of the central portion of the retina, the macula (Velez-Montoya et al. 2014). AMD is the leading cause of blindness in o...

Quest to prevent Macular degeneration continues with UA researcher's $1.7m NIH grant

(University of Arizona Health Sciences) After showing that individuals who take levodopa, or l-dopa, for movement disorders such as Parkinson's disease are protected from developing macular degenerati...

Nepafenac reduces risk for macular edema after cataract surgery in select patients

Two studies have shown the benefits of topical nepafenac 0.3% in reducing the risk for macular edema and pseudophakic cystoid macular edema in certain patients.For patients who exhibit risk factors fo...

High-dose intravitreal triamcinolone acetonide treats macular edema for up to 6 months

One injection of decanted high-dose intravitreal triamcinolone acetonide can provide a 6-month treatment for patients with treatment-resistant persistent macular edema, according to a study. Researche...

Vitrectomy yields more macular hole closures than Jetrea

BOSTON — Visual outcomes were similar in eyes with bilateral macular holes that underwent a vitrectomy or intravitreal ocriplasmin injection, but primary macular hole closure rates were higher in ey...

Wet Macular Degeneration Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Wet Macular Degeneration Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Wet Macular Degeneration in seven major markets US, France, Germany, Italy, Spain...

Drugs and Medications [104 Associated Drugs and Medications listed on BioPortfolio]

Lucentis [Genentech, Inc.]

These highlights do not include all the information needed to use LUCENTIS safely and effectively. See full prescribing information for LUCENTIS. LUCENTIS (ranibizumab injection)Intravitreal Injection...

Latanoprost [Greenstone LLC]

Latanoprost ophthalmic solution

Latanoprost [Apotex Corp.]

Latanoprost Ophthalmic Solution, 0.005%

Latanoprost [Paddock Laboratories, LLC]

Latanoprost Ophthalmic Solution, 0.005%

Latanoprost [Greenstone LLC]

Latanoprost ophthalmic solution

PubMed Articles [4093 Associated PubMed Articles listed on BioPortfolio]

Pesticide Use and Age-Related Macular Degeneration in the Agricultural Health Study.

Age-related macular degeneration (AMD) is a leading cause of blindness in developed countries. Few studies have investigated its relationship to environmental neurotoxicants. In previous cross-section...


To assess health care utilization and vision outcomes over 2 years in patients receiving bevacizumab treatment in clinical practice for diabetic macular edema.

Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration.

To measure visual acuity and metamorphopsia in patients with age-related macular degeneration (AMD) and to explore their relationship with macular lesions.


To compare the surgical outcome of a lamellar macular hole (LMH) depending on lamellar hole-associated epiretinal proliferation (LHEP) and full-thickness macular hole.

Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema.

To explore the relationships between macular thickness and the plasma concentrations of homocysteine, vitamin B12, folate, and other known risk factors for patients with diabetes without diabetic macu...

Clinical Trials [3190 Associated Clinical Trials listed on BioPortfolio]

Preoperative Progression of Macular Holes

Knowledge of the natural history and progression of macular holes is mainly limited to the studies from the pre-optical coherence tomography era. By observing macular holes preoperatively ...

Effects of Macular Buckle Versus Vitrectomy on Macular Schisis and Macular Detachment in Highly Myopic Eyes

Macular schisis associated with macular detachment is a one of the complications of high myopia. There is controversy in the primary treatment for this situation. This study will compare t...

Fundus Autofluorescence After Macular Hole Surgery

Funds autofluorescence (FAF) indicates hyper fluorescence at the macular hole in the patients with macular hole. Investigators investigate the association between FAF and visual acuity, re...

Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study

A macular hole is a fairly common problem in the retina and is an important cause of loss of central vision. The aim of this study is to determine whether, in patients with a stage 2 or 3 ...

Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration

The aim is to study the use of Ocusweep system especially in driving health evaluation and compare the results produced by Ocusweep system to those of conventional devices. The main focus ...

Companies [1777 Associated Companies listed on BioPortfolio]

Georgia Retina, P.C.

The physicians of Georgia Retina specialize in the diagnosis and treatment of diabetic retinopathy, macular pucker and macular holes, age-related macular degeneration, retinal detachment, proliferativ...

Macular Health

Macular Health, LLC

Ocata Therapeutics, Inc.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. Ocata’s most a...

Ocata Therapeutics, Inc.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of regenerative ophthalmology therapeutics. Ocata’s most a...

More Information about "Macular Health" on BioPortfolio

We have published hundreds of Macular Health news stories on BioPortfolio along with dozens of Macular Health Clinical Trials and PubMed Articles about Macular Health for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Macular Health Companies in our database. You can also find out about relevant Macular Health Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record